What is Leerink Partnrs’ Forecast for KROS FY2028 Earnings?
Keros Therapeutics, Inc. (NASDAQ:KROS – Free Report) – Equities researchers at Leerink Partnrs raised their FY2028 earnings per share estimates for Keros Therapeutics in a research note issued on Wednesday, February 5th. Leerink Partnrs analyst T. Smith now forecasts that the company will post earnings per share of ($2.03) for the year, up from their […]
Keros Therapeutics, Inc. (NASDAQ:KROS – Free Report) – Equities researchers at Leerink Partnrs raised their FY2028 earnings per share estimates for Keros Therapeutics in a research note issued on Wednesday, February 5th. Leerink Partnrs analyst T. Smith now forecasts that the company will post earnings per share of ($2.03) for the year, up from their […]
